Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 78; no. 4, S |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Association for Cancer Research
2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!